Respiratory disease in athletes encompasses a range of conditions that can impair lung function and performance, including exercise-induced bronchoconstriction, asthma, allergic rhinitis, and infections. High levels of physical activity and exposure to environmental stressors, such as cold air, pollutants, or chlorine in swimming pools, may trigger or worsen symptoms. Athletes may report shortness of breath during exertion, wheezing, persistent cough, or reduced exercise tolerance. Diagnosis involves detailed history-taking, pulmonary function testing, exercise challenge tests, and assessment of environmental and training factors. Accurate identification is critical to differentiate disease from normal physiological adaptations to high-intensity training.
Management strategies combine medical interventions, lifestyle adjustments, and training modifications. Pharmacologic therapies may include inhaled corticosteroids, bronchodilators, and leukotriene receptor antagonists, depending on the specific condition. Preventive measures, such as pre-exercise warm-up routines, airway humidification, and avoidance of triggers, are equally important. Pulmonary function monitoring and collaboration between sports physicians, pulmonologists, and trainers help optimize performance while minimizing respiratory complications. Education of athletes regarding early symptom recognition, adherence to treatment, and safe training environments is essential. Comprehensive respiratory care enables athletes to maintain peak performance while protecting long-term lung health.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation